Perspective on biotech leaders

Blue Latitude Health|27th November 2017

The future of healthcare starts here...

As 2017 draws to a close we speak to seven biotech leaders, ranging from CEO's to medical information leaders and marketing directors, as well as genomics experts, clinical diagnostic professionals and academics.

In each interview these trailblazers reveal exclusive deep insights into the future of the industry, exploring how changes in pricing, regulation and technological and scientific innovation are transforming the way we view healthcare.

Download the magazine to find out about:

  • Commercialising cutting-edge stem cell therapies
  • The patient-centric heart of the industry
  • The changing role of medical information in precision medicine
  • What commercial innovation really means for biotech companies
  • How to overcome the skills crisis plaguing the sector
  • The future of clinical diagnostics and liquid biopsy
  • Big data, privacy and the rise of genomic testing.
 

Launch Excellence 2020

Blue Latitude Health|18th November 2019

In this publication, we explore what makes a successful pharma launch from developing insight that drives behaviour change to lean launches and multi-indication launches, as well as an evaluation of the CAR-T market.

read more

Precision medicine at Blue Latitude Health

Blue Latitude Health|7th November 2019

At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and launch of precision medicines.

read more

Understanding the evolving CAR-T market

Ditte Funding, Maria Katsarou, Natasha Cowan|1st November 2019

In 2017 the approval of the first CAR-T treatment took the world by storm, transforming the way cancer is treated, but two years later more than 500 CAR-Ts are in development. So how can pharma ensure its product stands out from the crowd?

read more